Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Benzyl Alcohol is restricted in cosmetic products under Annex III of the EU Cosmetics Regulation (EC) 1223/2009.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 70/100 (high) · high confidence.
Regional restrictions
Prevalence of BENZYL ALCOHOL in our catalog (epa_cpdat).
Products
9,929
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
EU
EC
Annex III of EU Cosmetics Regulation (EC) 1223/2009: substances which cosmetic products must not contain except subject to the restrictions laid down. Product types: (a) Solvent (b) Fragrance/ aromatic compositions/ their raw materials Other conditions: For purposes other than inhibiting the development of microorganisms in the product. This purpose has to be apparent from the presentation of the product. The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.
EU
EC
Annex V of EU Cosmetics Regulation (EC) 1223/2009: preservatives allowed in cosmetic products. Maximum concentration: 1.0%
Crema Manos
S'nonas
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
US
EPA
EPA CPDat observed this chemical in 9929 composition records across product categories including Raw materials, Industrial products, Construction. EPA CPDat classifies this chemical for functional uses including Preservative, Solvent, Fragrance.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.9 %w/v
US
FDA
Route: ENDOTRACHEAL; Dosage form: INJECTION; Maximum daily exposure: 54 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION; Potency: 0.9 %w/v
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 1 %w/v
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 23 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
US
FDA
Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 18 mg
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.01 ml
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 8.4 mg
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 23 mg
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 20 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 1000 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 225 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 144 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 500 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Maximum daily exposure: 54 mg
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 18 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1620 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 45 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 144 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 400 mg
US
FDA
Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 1.04 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 242 mg
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 5 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Potency: 5 mg/1ml
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 450 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 1.23 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 2.31 mg
US
FDA
Route: RECTAL; Dosage form: GEL; Maximum daily exposure: 124 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 129 mg
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 23 mg
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
US
FDA
Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Maximum daily exposure: 252 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 90 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 225 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.95 %w/v
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 160 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 185 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 4000 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 2.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1.25 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 2 %w/w
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION; Potency: 1 %w/w
US
FDA
Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 100 mg
US
FDA
FDA NDC lists this ingredient in 24 active drug products and 29 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.